CFO THOUGHT LEADER

The Future of Finance is Listening
undefined
Dec 11, 2019 • 36min

555: Two Worlds One Career | Mike Kaseta, CFO, Aerami Therapeutics

Few megadeals within the past decade have received as many recurring kudos as the acquisition of Genzyme, of Cambridge, MA by France’s biggest pharmaceutical company, Sanofi. The marriage of Sanofi and Genzyme appears to have exceeded expectations, allowing all of those involved in minting the newly merged entity to rightfully keep a feather in their postmerger caps. Thus it was for Mike Kaseta, who in the wake of the merger found himself tasked with integrating the finance and IT functions of the two companies. “It’s probably the achievement that I’m most proud of in my career,” explains Kaseta, who, after nearly a decade climbing the finance ranks inside Sanofi, exited the giant pharmaceutical company to stake a claim inside the realm of early-stage biotech, where today he is CFO of Aerami Therapeutics. Looking back, Kaseta believes that the greatest lessons he gleaned from the Sanofi–Genzyme merger were people-related: “There was no iron fist. We listened to employees. We understood. In the end, we had no control deficiencies, no comments from our external auditors, and the integration occurred in a timely manner.” Looking forward, Kaseta says that raising money now tops his list of CFO priorities at Aerami. “We have to get our story out,” he adds. “We have to get it out to the right people and really engage with investors, allowing them to get as excited about our story as we are.” –Jack Sweeney Do you want to learn more about the experiences that shaped today’s finance leaders? GO PREMIUM with CFO Thought Leader and each quarter we will ship you our CFO Thought Leader Quarterly Magazine featuring profiles of 25 different CFOs (4 issues, per yr.). What’s more, become a PREMIUM member before February 1, 2020 and we’ll ship you THE CFO Yearbook 2020  featuring 100 CFO profiles. Go Premium today learn more
undefined
Dec 9, 2019 • 1h 1min

554: Achieving a Strategic Capital Structure | David Moss, CFO INmune Bio

David Moss, CFO and co-founder of INmune Bio, shares lessons from his 25-year finance career, including the infamous '$3 million sweatshirt' from his Pets.com investment. He emphasizes the need for clear communication with both retail and institutional investors in biotech. Moss also discusses his journey from entrepreneurship to CFO, the importance of a straightforward capital structure, and strategies for financial reporting during clinical trials. Joining him is Glenn Snyder, who highlights the vital role of FP&A in supporting strategic decisions at Digital Realty.
undefined
Dec 4, 2019 • 40min

553: Rebuilding a Spin-off's Missing Parts | Ravi Chopra, CFO, SonicWall

Ravi Chopra has built his career inside finance functions designed to serve growth-minded management. Such was the case in the late ’90s when Chopra joined Cisco Systems, which at the time was experiencing 50% growth annually. Jump forward 10 years, and you’ll find him busy leading the FP&A function for growth-driven Juniper Networks. Asked to reflect back on a 25-year finance career, Chopra doesn’t hesitate to cite his former employer. “I learned most of everything that I know today at Juniper,” says Chopra, who quickly names Robyn Denholm, Juniper’s former CFO and current Tesla chairman, as a present and former mentor. Still, when the door to the CFO office swung open for Chopra, the accomplished finance executive no doubt found his operations knowledge being put to the test. In 2017, Chopra would exit Juniper Networks and take on the CFO role at SonicWall, a company that had neither a finance nor an HR organization after it split off from Dell, Inc., in late 2016. Dell had acquired SonicWall in 2012 but divested the business along with Quest Software as part of the larger Dell EMC integration. Despite some missing parts, SonicWall arguably split off with something far more valuable intact: its brand name. Prior to being acquired by Dell, the cyber protection company had long since established itself as a leader in the small and midsize business space. “It was just an amazing challenge, and I think that we have now come out on the other side of it rather well,” explains Chopra, who believes that the speed with which SonicWall built its new infrastructure and achieved operational efficiencies allowed the firm to more quickly determine where to allocate capital. –Jack Sweeney Do you want to learn more about the experiences that shaped today’s finance leaders? GO PREMIUM with CFO Thought Leader and each quarter we will ship you our CFO Thought Leader Quarterly Magazine featuring profiles of 25 different CFOs (4 issues, per yr.). What’s more, become a PREMIUM member before February 1, 2020 and we’ll ship you THE CFO Yearbook 2020  featuring 100 CFO profiles. Go Premium today learn more
undefined
Dec 1, 2019 • 42min

552: Making Customer Outcomes Top of Mind | Valerie Burman, CFO, Guidespark

Had Valerie Burman entered the CFO office a decade ago, you wonder whether the role would be as good a match for the accomplished finance executive as it appears to be today. Back in 2007, after working nearly a decade in M&A as an investment banker, Burman exited a banking career to take on a corporate development role at Business Objects, a French software company that was soon to be acquired by SAP. Post acquisition, Burman quickly found a groundswell of opportunities coming her way inside SAP, where she would serve in a variety of roles involving technology partnerships, business development, and product management.  Fast-forward a few years, and we find Stanford Law graduate Burman serving as general counsel first to Mindjet and then to crowdsourcing innovation upstart Spigit. “I would say that working from those perspectives—although it is a bit of a roundabout way to become a CFO—has really led me to a place where I can be a CFO with a business-minded, strategic approach,” says Burman, who points out that along the way, she was given the opportunity to closely observe the board room decision-making behind certain acquisitions designed to drive growth. “The breadth of experiences that I have taken with me are not necessarily specific to my core finance role, but speak to my ability to understand cross-functionally what’s important to my peers,” Burman observes, while underscoring the growing cross-functional role that finance plays in business today. For just as Burman’s resume has evolved, so too has the role of CFO. – Jack Sweeney Do you want to learn more about the experiences that shaped today’s finance leaders? GO PREMIUM with CFO Thought Leader and each quarter we will ship you our CFO Thought Leader Quarterly Magazine featuring profiles of 25 different CFOs (4 issues, per yr.). What’s more, become a PREMIUM member before February 1, 2020 and we’ll ship you THE CFO Yearbook 2020  featuring 100 CFO profiles. Go Premium today learn more
undefined
Nov 24, 2019 • 37min

551: Capitalizing on Efficiencies to Unlock New Value | Chris Sands, CFO, MineralTree

When Chris Sands accepted an investor relations position at a midsize health care firm, he did so with the understanding that he would be permitted to occasionally sink his teeth into some of the firm’s growing FP&A challenges. Having a resume rich with investment banking experience, Sands was now determined to add some FP&A, a tour of duty that he viewed as a necessary prerequisite if he were going to advance down the CFO path. Unbeknownst to Sands, his FP&A plate would shortly be overflowing following the acquisition of his new employer by Thermo Fisher Scientific of Waltham, Massachusetts. In the aftermath, Sands was enlisted to help lead the science giant’s planning function, which allowed him to dine regularly on high-calorie planning and begin to consider his next opportunity. Sands would open what he views as the third chapter of his career at MineralTree, after having been recruited by CEO Micah Remley, with whom Sands had worked earlier in his career. “Anytime a company is looking to hire a CFO, they inevitably ask for CFO experience as if people are born with it, so, for me, getting that experience became really important,” observes Sands, who describes his decision to join MineralTree as a “no-brainer.” Looking back, Sands says that he would advise up-and-coming finance executives to actively seek out leadership mentors and not hesitate when it comes to expressing aspirations to become a CFO. Says Sands: “People aren’t mind readers, but if they are a true mentor and know what your aspirations are, they will seek to enable you on your journey.” –Jack Sweeney Do you want to learn more about the experiences that shaped today’s finance leaders? GO PREMIUM with CFO Thought Leader and each quarter we will ship you our CFO Thought Leader Quarterly Magazine featuring profiles of 25 different CFOs (4 issues, per yr.). What’s more, become a PREMIUM member before February 1, 2020 and we’ll ship you THE CFO Yearbook 2020  featuring 100 CFO profiles. Go Premium today learn more
undefined
Nov 20, 2019 • 38min

550: The Funnel: Where Sales & Finance Meet | Andrew Hicks, CFO, Advanced

For every top sales leader who confides to friends that he or she is really a numbers freak at heart, there’s an Andrew Hicks, who, as CFO of Advanced, would be just as apt to boast about a sales funnel innovation as he would about the adoption of a new accounting rule. In fact, it would probably not surprise Hicks’s past and present business colleagues to learn that when asked to identify a mentor from his past, Advanced’s CFO chooses the head of sales for a former employer. “It was because of this relationship that I first experienced an inkling of how people can think about the business differently and think differently about what drives value in the firm,” explains Hicks, who found his mentor after being transferred to Austin from London by Misys, a UK-based software developer that today is part of Finastra. “I had moved across the world, and the sales leader took me under his wing a bit as someone new in the U.S. who didn’t really have family or friends nearby. Talking to him really piqued my interest in learning more about how the business worked,” recalls Hicks, who would remain in the U.S. for nine years before being recruited for a CFO role back in London. Along the way, Hicks’s professional network became energized via a budding relationship with private equity firm Vista Equity Partners, which enlisted him as an advisor after Vista bought a portion of Misys’s healthcare business. “Vista is continually working its network to find talent, and I was found by that means,” says Hicks, whose CFO career chapter has to date been populated by multiple Vista-owned companies. –Jack Sweeney  Do you want to learn more about the experiences that shaped today’s finance leaders? GO PREMIUM with CFO Thought Leader and each quarter we will ship you our CFO Thought Leader Quarterly Magazine featuring profiles of 25 different CFOs (4 issues, per yr.). What’s more, become a PREMIUM member before February 1, 2020 and we’ll ship you THE CFO Yearbook 2020  featuring 100 CFO profiles. Go Premium today learn more
undefined
Nov 17, 2019 • 38min

549: Stay the Course | Cort Townsend, CFO, Kofax Software

As is the case with many finance leader resumes, Cort Townsend’s reveals a repetition of professional advancement and achievement that allows casual readers to quickly validate his CFO credentials. However, like those of many, Townsend self-tale is only a shorthand rendering of a career path filled with twists, turns, and high-stakes industry drama. Such was the case in 2015 and 2016, a period in Townsend’s career annals with enough M&A high jinks and boardroom intrigue to fill an entire volume. Subsequently, though, in July 2017, Townsend landed neatly inside the CFO office of Kofax via an appointment that casual readers of his resume might have assumed was the natural next step for a dedicated senior executive who had already served as the firm’s controller and vice president of finance. So, where was all the drama? Lost between the lines of Townsend’s resume was the acquisition of Kofax by Lexmark International in 2015 and the subsequent acquisition of Lexmark by Apex Technology in 2016. Along the way, Townsend was named finance chief of Lexmark’s enterprise software group, which turned out to be an abbreviated tour of duty that made him the obvious choice for a C-suite posting when Lexmark opted to spin off the software group in late 2016 and later sell it to private equity firm Thoma Bravo. The sale of the group would be completed in July 2017, the very month in which Townsend was appointed CFO of newly branded Kofax. Witness just the type of swift-moving, complex narrative that allows even detail-oriented leaders like Townsend to much appreciate the virtues of a shorthand bio. –Jack Sweeney   Do you want to learn more about the experiences that shaped today’s finance leaders? GO PREMIUM with CFO Thought Leader and each quarter we will ship you our CFO Thought Leader Quarterly Magazine featuring profiles of 25 different CFOs (4 issues, per yr.). What’s more, become a PREMIUM member before February 1, 2020 and we’ll ship you THE CFO Yearbook 2020  featuring 100 CFO profiles. Go Premium today learn more
undefined
Nov 13, 2019 • 44min

548: Raising Your Finance Voice | Mahesh Patel, CFO, Druva

A brief summary of this episode
undefined
Nov 10, 2019 • 39min

547: Enters the Change Agent | John Karnes, CFO, Vertafore

CFOTL: What are your top of mind metrics? Karnes: I think about metrics sort of under three rubrics. The first is what I would think of as a customer-centric layer. Then there's the financial performance one that we all think about as CFOs, and then there's a very distinct operational layer. On the customer-centric layer, we think about things like SLAs, our service-level agreements with our customers, uptime, system availability. These are the things--before we get to gross margin--that really impact our success as a business and what our next quarter is going to be like. There are things like customer health scoring in your customer success organization. Happy customers don't leave. Keeping your revenue is much cheaper than trying to go acquire new revenue. Things like NPS, net promoter score. Things that I watch very, very carefully are very customer-centric, as opposed to what's next, which is more pure financial performance. At the end of the day, your economics are based on your base business, your new business, and the investments that you make going forward. That's what drives economic performance. The first thing that I look at in the morning is churn and retention. "Churn," for those who aren't SaaS experts, is simply our subscriptions that are terminating and my customers that are leaving me or deciding to subscribe to me in a lesser amount. So, it's lost revenue. After that, it's gross margin. Obviously revenue is tops. Churn is my top line. Gross margin is after my cost of goods sold and tells me how efficiently I'm delivering my product. All of these businesses are built on free cash flow. After I pay my G&A, after I pay the capex that I've got, how much cash am I making and am I self-sufficient or dependent on the equity markets to grow my business? That's a really important part of the business, from a baseline. New business cost is very important. These are things like customer acquisition costs. I'm making an investment for every customer. How quickly do I get that investment back? How many months? Is it six, 12, 18 months before I recoup that investment? And, like all good SaaSware companies, we invest a tremendous amount of money in our future through research and development. The question is, What is the rate of return that we're engineering to for that research and development? How does this correlate with other opportunities that we may have, like acquisitions or debt repayment?
undefined
Nov 6, 2019 • 40min

546: When Speed to Market Matters Most | Richard Steinhart, CFO, Bioxcel Therapeutics

When asked what sets BioXcel Therapeutics apart from other clinical-stage biopharmaceutical companies, CFO Richard Steinhart doesn’t mention a specific drug or therapy. Instead, he describes a system that the company developed to advance the speed with which drugs are commercialized. According to Steinhart, the biotech company’s system uses artificial intelligence to reveal “hidden connections” that, once exposed, can multiply opportunities for the application of certain drugs. “Good drug developers can see first connections between drugs and diseases and they are pretty apparent to everyone out there, but second- and third-degree connections are not apparent,” explains Steinhart, who says that such connections have been too time-consuming and expensive to expose in the past. “The last company I was with took 10 years to go from the discovery (of a drug to the licensing of the discovery to a phase two trial,” adds Steinhart, who reveals that it was BioXcel’s system for shortening the path to commercialization that first attracted him. –Jack Sweeney Do you want to learn more about the experiences that shaped today’s finance leaders? GO PREMIUM with CFO Thought Leader and each quarter we will ship you our CFO Thought Leader Quarterly Magazine featuring profiles of 25 different CFOs (4 issues, per yr.). What’s more, become a PREMIUM member before February 1, 2020 and we’ll ship you THE CFO Yearbook 2020  featuring 100 CFO profiles. Go Premium today learn more

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app